BioVision, Inc. Press releases
Oct 12, 2016
ELISA (Enzyme-linked immunosorbent assay) kit is a simple and cost-effective method for detecting and quantifying an antigen in various samples such as serum, plasma and cell culture and other biological fluids.
Sep 23, 2016
Methyltransferases are a diverse group of enzymes that methylate proteins, DNA, and small molecule targets. Accordingly, methyl transferase activity plays a critical role in modulating gene transcription, protein interactions, and signaling networks.
Aug 16, 2016
Prostate Specific Antigen (PSA) or Kallikrein-related peptidase3, is a serine protease that proteolyses Semenogelin I and Semenogelin II in seminal fluid and thus liquefying it.
Aug 15, 2016
BioVision introduces Phospho-p38 MAPK (Thr¹⁸⁰+Tyr¹⁸²) Translocation Assay Kit (Cell-Based) for research in the areas of inflammation, stress,autophagy, cell differentiation and many others.
Aug 04, 2016
BioVision proudly announces the launch of highly pure and effective recombinant Cas9 proteins, Antibodies, Homology Directed Repair (HDR) Blockers and Enhancers for Genome Editing Studies using CRISPR/Cas9 Technology.
Jul 07, 2016
Exosomes are small endosome derived lipid nanoparticles (50-120 nm in diameter) actively secreted by exocytosis in most living cells.
May 19, 2016
BioVision proudly announces the launch of the Molecular Bology Grade Fabulously Active FabActTM Proteinase K (recombinant), which is the most powerful proteinase among all proteinases characterized so far.
May 10, 2016
BioVision proudly announces the launch of GeneGlideTM Transfection Reagents that are ideal for delivering nucleic acids including DNA, siRNA, miRNA to mammalian cells.
May 06, 2016
BioVision, Inc., proudly announces the launch of a Multidrug Resistance Assay Kit. The assay can be HTP adaptable and does not require special equipment.
Apr 13, 2016
Trial size antibodies are convenient and economical solution for researchers to explore several targets for screening. BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.